As with all GLP-1 therapies, there are important safety considerations: Not suitable for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) May cause nausea, vomiting, diarrhea , especially during dose titration Monitor for signs of pancreatitis , gallbladder issues, or allergic reactions Not indicated for patients with Type 1 diabetes or those with severe gastrointestinal disorders Regular follow-ups, lab monitoring, and dose adjustments are part of the DrWell Methodology to ensure safe, effective outcomes
It must be said that there is no one-size-fits-all diet that must be prescribed when a patient is offered therapy with a GLP-1 or GLP/GIP medication
However, its crucial for anyone considering Tirzepatide for weight loss to consult with a healthcare professional
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER "For example, severe vomiting can result in serious dehydration and electrolyte imbalances, which can be dangerous if left untreated," she told Fox News Digital